Today, crystallization is used primarily to analyze the structures of proteins. It also is gaining favor as a purification method for elastase, proteases, albumin, and lipase, in addition to ...

The growing complexity of antibody therapeutics has driven rapid innovation in downstream processing. As novel formats such as bispecifics, fragments and antibody–drug conjugates (ADCs) expand, so ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

Next-generation monoclonal antibodies (mAbs), including bispecifics and multimerized formats, present increasingly complex purification challenges. Unique structural features and elevated impurity ...

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Purification’s new purification technology platform, under the 3M Emphaze™ brand, is designed to help biopharmaceutical manufacturers achieve high product purity ...